Science Current Events | Science News | Brightsurf.com
 

Metformin Current Events | Metformin News

Page 1 of 1 | 24 Results
Previous01   Next   
Sort By: Page Views | Date
Diabetes medication and lifestyle changes can help treat weight gain induced by antipsychotic drugs
Lifestyle intervention and the drug metformin are both effective against antipsychotic-induced weight gain, and treatment is most effective when the two therapies are combined, according to a study in the January 9/16 issue of JAMA.   view more (2008-01-09)

Standard therapy more effective than diabetes drug in helping women with PCOS achieve pregnancy
Metformin, a drug used to treat diabetes and once thought to have great promise in overcoming the infertility associated with polycystic ovary syndrome (PCOS), is less effective than the standard fertility drug treatment, clomiphene.   view more (2007-02-08)

Drug could improve pregnancy outcomes in wider range of women with insulin resistance
Women who are obese, have type 2 diabetes or a family history of type 2 diabetes could one day have more successful pregnancies because of a study at Washington University School of Medicine in St. Louis.   view more (2007-09-07)

Metformin increases pathologic complete response rates in breast cancer patients with diabetes
Metformin, the common first-line drug for type 2 diabetes, may be effective in increasing pathologic complete response rates in diabetic women with early stage breast cancer who took the drug during chemotherapy prior to having surgery, paving the way for further research of the drug as a potential... view more (2008-06-03)

Standard treatment more effective than diabetes drug for achieving pregnancy in fertility disorder
Metformin, a drug used to treat diabetes and thought to hold great promise at overcoming the infertility associated with polycystic ovary syndrome (PCOS), is less useful for helping women with the condition achieve pregnancy than is the standard treatment with the infertility drug clomiphene,... view more (2007-02-08)

Traditional Chinese medicine for diabetes has scientific backing
Reports of a traditional Chinese medicine having beneficial effects for people suffering from type 2 diabetes now has some scientific evidence to back up the claims.   view more (2006-08-01)

Weight loss improves bladder control in women with prediabetes
Losing a modest amount of weight through dietary changes and increased physical activity reduces the occurrence of urinary incontinence (UI) in women with prediabetes, a condition in which blood glucose levels are higher than normal but not yet diabetic.   view more (2006-01-27)

New 4-year Study To Examine Effects Of Reducing Insulin Resistance On Cardiovascular Risk
Takeda UK Ltd (Takeda) today confirmed that 60 UK centres will participate in the PROspective pioglitAzone Clinical Trial In macroVascular Events (PROactive). PROactive will enroll 5,000 patients in 10 European countries and will last four years. Of the 5,000 patients who will be enrolled it is... view more (2001-08-29)

Risks of sulfonylurea drugs in the treatment of diabetes mellitus
Sulfonylurea drugs, used in the treatment of patients with diabetes mellitus to lower blood sugar levels, have been suspected since the 1970s of increasing cardiovascular mortality as well.   view more (2006-01-17)

ACTOS (PIOGLITAZONE): NEW THERAPY FOR TYPE 2 DIABETES WITH NOVEL MODE OF ACTION LAUNCHED IN UK
“Type 2 diabetes is characterised by high blood sugar but also by lipid abnormalities, particularly raised triglycerides and low HDL (so-called good) cholesterol. This spectrum of metabolic imbalance related to insulin resistance together with raised blood pressure is the characteristic... view more (2000-11-07)

Drugs to combat effects of a couch potato lifestyle
Discoveries made at the University of Dundee are helping in the development of drugs that fool your body into thinking that you are actively exercising even when you are not, and may help in the fight against the current increase in the incidence of obesity and Type 2 diabetes. Professor Grahame... view more (2002-03-04)

Researchers discover gene mutation thought to control energy levels
This study focused on the gene for AMPK (adenosine monophosphate-activated protein kinase), which controls the amount of energy in our cells by becoming active when fuel stores start to deplete, such as during exercise.   view more (2007-09-19)

NASH Clinical Research Network Launches Trial for Treatment of Liver Disease in Children
The Nonalcoholic Steatohepatitis (NASH) Clinical Research Network has launched its second clinical trial to study NASH, a liver disease that resembles alcoholic liver disease but occurs in patients who drink little or no alcohol.   view more (2005-09-29)

Expert Reviews Cannot Be Trusted
The results of the most important research in diabetes in the past 25 years have not been conveyed accurately to doctors, claim researchers in this week's BMJ. These findings have far reaching implications for how the current medical information system transmits new research results from academia... view more (2003-07-30)

Incidence of Fatty Liver Disease rises as obesity in children increases
Indiana University School of Medicine researchers are taking a closer look at a disease whose incidence is rising as obesity in children increases. Non-Alcoholic Steatohepatitis, more popularly known as Fatty Liver Disease, occurs in approximately 15% of obese children.   view more (2007-03-16)

No 'convincing evidence' that glitazones work better than older diabetes drugs
There is no convincing evidence that the newer class of diabetes drugs, known as glitazones, offer real advantages over other diabetes drugs, when used on their own, concludes the Drug and Therapeutics Bulletin (DTB).   view more (2008-04-10)

Widely prescribed diabetes drug falls short of promise, says new review
A new systematic review calls into the question the health benefits versus risks of an oral medicine widely prescribed for diabetes throughout the United States, Canada, Europe and Asia.   view more (2006-10-18)

If the diabetes has a direct carcinogenetic effect?
The association of DM2 with solid tumors, and particularly with HCC, has been long suspected and several studies have reported increased mortality rates for neoplastic diseases in patients with DM2.   view more (2008-10-29)

Moderate use averts failure of type 2 diabetes drugs in animal model
Drugs widely used to treat type 2 diabetes may be more likely to keep working if they are used in moderation, researchers at Washington University School of Medicine in St. Louis have found in a study using an animal model.   view more (2008-10-28)

Pycnogenol delays glucose absorption 190 times more potently than prescription medication
A new study to be published in an upcoming edition of the journal of Diabetes Research and Clinical Practice reveals that French maritime pine tree extract known as Pycnogenol® (pic-noj-en-all) delays the uptake of glucose from a meal 190 times more than prescription medications, preventing the... view more (2007-02-08)

Common rheumatoid arthritis treatment shows potential for diabetes prevention
Far fewer rheumatoid arthritis patients treated with the drug hydroxychloroquine (HCQ) went on to develop diabetes compared to those who never took the drug.   view more (2007-07-11)

Lancet publishes proactive study: Diabetes treatment reduces risk of heart attacks & strokes
A study published in The Lancet today shows that Takeda's ACTOS® (pioglitazone HCl), an oral glucose lowering medication, significantly reduces the combined risk of non-fatal heart attacks, strokes and deaths by an additional 16% on top of standard medication, such as statins, fibrates, ACE... view more (2005-10-10)

Study shows pine bark naturally reduces cardiovascular risk factors in diabetics
A new study published in the May 2008 (volume 8, issue 25) edition of the journal of Nutrition Research shows Pycnogenol (pic-noj-en-all), an antioxidant plant extract from the bark of the French maritime pine tree, reduces blood sugar in type II diabetes patients, allows people to lower their... view more (2008-05-29)

Gene variant increases risk of type 2 diabetes
Researchers have confirmed that a gene variant confers susceptibility to type 2 diabetes in participants of the Diabetes Prevention Program (DPP), a large clinical trial in adults at increased risk for developing type 2 diabetes.   view more (2006-07-20)
Page 1 of 1 | 24 Results
Previous01   Next   
Sort By: Page Views | Date
© 2008 BrightSurf.com